Matches in SemOpenAlex for { <https://semopenalex.org/work/W3167658890> ?p ?o ?g. }
- W3167658890 endingPage "524" @default.
- W3167658890 startingPage "505" @default.
- W3167658890 abstract "Lung cancer is the most frequently diagnosed type of cancer and the main cause of death from malignant neoplasms worldwide. One of the most recent discoveries in the context of non-small cell lung cancer (NSCLC) was the mutation of the anaplastic lymphoma kinase receptor (ALK). This genetic alteration is found in approximately 2-5% of NSCLC patients, and crizotinib was the first targeted therapy discovered for its first-line treatment.To conduct a systematic review and meta-analysis to estimate the magnitude of the overall survival (OS) and progression-free survival (PFS) from using crizotinib as treatment compared to traditional chemotherapy to guide future decision making.PRISMA and Cochrane recommendations were followed using the findings based on studies published in the main international electronic databases. Selection criteria included the following: randomized clinical trials (RCT) or cohort studies that had assessed the efficacy and effectiveness of crizotinib as monotherapy in patients with NSCLC with ALK fusions.From 2504 publications identified in the literature, only eight publications referring to seven studies met the selection criteria, with high heterogeneity identified between the studies. Overall, there was a significant gain in PFS (HR 0.38; 95% CI 0.30-0.49; p < 0.00001); however, there was no significant gain in OS (HR 0.68; 95% CI 0.43-1.08; p = 0.10).The study highlighted and confirmed that treatment with crizotinib led to clinical improvement in PFS among patients with advanced NSCLC with ALK fusion, as previously reported. However, there was no increase in overall survival in patients with NSCLC with genetic alterations of ALK. This must be considered when reviewing and funding treatments for NSCLC patients with this mutation." @default.
- W3167658890 created "2021-06-22" @default.
- W3167658890 creator A5015244722 @default.
- W3167658890 creator A5016116910 @default.
- W3167658890 creator A5028480298 @default.
- W3167658890 creator A5037901471 @default.
- W3167658890 creator A5063434434 @default.
- W3167658890 creator A5067159712 @default.
- W3167658890 creator A5084443733 @default.
- W3167658890 date "2021-06-11" @default.
- W3167658890 modified "2023-10-18" @default.
- W3167658890 title "Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis" @default.
- W3167658890 cites W1992447906 @default.
- W3167658890 cites W2019607817 @default.
- W3167658890 cites W2075894019 @default.
- W3167658890 cites W2087544847 @default.
- W3167658890 cites W2099530756 @default.
- W3167658890 cites W2141714716 @default.
- W3167658890 cites W2170716949 @default.
- W3167658890 cites W2174423882 @default.
- W3167658890 cites W2280669508 @default.
- W3167658890 cites W2416907124 @default.
- W3167658890 cites W2471664064 @default.
- W3167658890 cites W2535472729 @default.
- W3167658890 cites W2567362164 @default.
- W3167658890 cites W2602191825 @default.
- W3167658890 cites W2604868172 @default.
- W3167658890 cites W2715907327 @default.
- W3167658890 cites W2733307304 @default.
- W3167658890 cites W2761198089 @default.
- W3167658890 cites W2782109468 @default.
- W3167658890 cites W2788728681 @default.
- W3167658890 cites W2791162311 @default.
- W3167658890 cites W2795514639 @default.
- W3167658890 cites W2803802743 @default.
- W3167658890 cites W2887380463 @default.
- W3167658890 cites W2889646458 @default.
- W3167658890 cites W2890742011 @default.
- W3167658890 cites W2891551818 @default.
- W3167658890 cites W2902826637 @default.
- W3167658890 cites W2909058039 @default.
- W3167658890 cites W2924630395 @default.
- W3167658890 cites W2945951151 @default.
- W3167658890 cites W2964471257 @default.
- W3167658890 cites W2972019220 @default.
- W3167658890 cites W2972079805 @default.
- W3167658890 cites W2977497532 @default.
- W3167658890 cites W2981392910 @default.
- W3167658890 cites W2998945641 @default.
- W3167658890 cites W3007156832 @default.
- W3167658890 cites W3008609132 @default.
- W3167658890 cites W3017107411 @default.
- W3167658890 cites W3022903699 @default.
- W3167658890 cites W3041104619 @default.
- W3167658890 cites W3082500459 @default.
- W3167658890 cites W4245115391 @default.
- W3167658890 doi "https://doi.org/10.1007/s40487-021-00155-3" @default.
- W3167658890 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8594233" @default.
- W3167658890 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34117602" @default.
- W3167658890 hasPublicationYear "2021" @default.
- W3167658890 type Work @default.
- W3167658890 sameAs 3167658890 @default.
- W3167658890 citedByCount "5" @default.
- W3167658890 countsByYear W31676588902021 @default.
- W3167658890 countsByYear W31676588902022 @default.
- W3167658890 countsByYear W31676588902023 @default.
- W3167658890 crossrefType "journal-article" @default.
- W3167658890 hasAuthorship W3167658890A5015244722 @default.
- W3167658890 hasAuthorship W3167658890A5016116910 @default.
- W3167658890 hasAuthorship W3167658890A5028480298 @default.
- W3167658890 hasAuthorship W3167658890A5037901471 @default.
- W3167658890 hasAuthorship W3167658890A5063434434 @default.
- W3167658890 hasAuthorship W3167658890A5067159712 @default.
- W3167658890 hasAuthorship W3167658890A5084443733 @default.
- W3167658890 hasBestOaLocation W31676588901 @default.
- W3167658890 hasConcept C117643217 @default.
- W3167658890 hasConcept C121608353 @default.
- W3167658890 hasConcept C126322002 @default.
- W3167658890 hasConcept C143998085 @default.
- W3167658890 hasConcept C151730666 @default.
- W3167658890 hasConcept C168563851 @default.
- W3167658890 hasConcept C2776232967 @default.
- W3167658890 hasConcept C2776256026 @default.
- W3167658890 hasConcept C2779343474 @default.
- W3167658890 hasConcept C2779422266 @default.
- W3167658890 hasConcept C2781230642 @default.
- W3167658890 hasConcept C71924100 @default.
- W3167658890 hasConcept C86803240 @default.
- W3167658890 hasConcept C95190672 @default.
- W3167658890 hasConceptScore W3167658890C117643217 @default.
- W3167658890 hasConceptScore W3167658890C121608353 @default.
- W3167658890 hasConceptScore W3167658890C126322002 @default.
- W3167658890 hasConceptScore W3167658890C143998085 @default.
- W3167658890 hasConceptScore W3167658890C151730666 @default.
- W3167658890 hasConceptScore W3167658890C168563851 @default.
- W3167658890 hasConceptScore W3167658890C2776232967 @default.
- W3167658890 hasConceptScore W3167658890C2776256026 @default.
- W3167658890 hasConceptScore W3167658890C2779343474 @default.